𝔖 Bobbio Scriptorium
✦   LIBER   ✦

New strategies in diagnosis and treatment of thrombotic thrombocytopenic purpura: case report and review

✍ Scribed by J. Häberle; B. Kehrel; J. Ritter; H. Jürgens; B. Lämmle; M. Furlan

Publisher
Springer
Year
1999
Tongue
English
Weight
150 KB
Volume
158
Category
Article
ISSN
0340-6997

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Thrombotic thrombocytopenic purpura and
Thrombotic thrombocytopenic purpura and pregnancy: report of four cases and literature review
✍ Ali Shamseddine; Aref Chehal; Ihab Usta; Ziad Salem; Nagi El-Saghir; Ali Taher 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB 👁 1 views

## Abstract Thrombotic thrombocytopenic purpura (TTP) is a severe life‐threatening hematological disorder affecting the microcirculation of multiple organ systems. Infection, pregnancy, cancer, drugs, and surgery are frequently associated with the initial episodes and relapses. Women who are either

Concurrent thrombotic thrombocytopenic p
Concurrent thrombotic thrombocytopenic purpura and immune thrombocytopenic purpura in an HIV-positive patient: Case report and review of the literature
✍ Yospur, Lisa S.; Sun, Nora C.J.; Figueroa, Priscilla; Niihara, Yutaka 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 495 KB 👁 2 views

Immune thrombocytopenlc purpura (ITP) and thrombotic thrombocytopenlc purpura (lTP) have each been associated with HIV Infection. Sequential occurrence of these two dlseases with a disease-free interval has been occasionally reported In the literature, whereas simultaneous manifestations of these tw

Rituximab for the treatment of refractor
Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): Report of three cases
✍ Lydia Koulova; Doru Alexandrescu; Janice P. Dutcher; Kevin P. O'Boyle; Saji Eape 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 162 KB 👁 2 views

Three patients (one with idiopathic thrombocytopenic purpura [ITP] and two with thrombotic thrombocytopenic purpura [TTP]) were treated with rituximab (anti-CD20 chimeric antibody) at a dose of 325 mg/m 2 administered weekly after they failed standard therapies. The patient with ITP who did not resp